Mr. Hermes Chan reports

MEDMIRA ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION

MedMira Inc. has appointed Markus Meile as the company's chief financial officer. Effective immediately, Mr. Meile replaces Jelle Kuypers, who has chosen to depart the company. Mr. Meile's proficiency in international finance, in addition to his experience in the medical device industry, makes him a valued member of the company's executive leadership team as it drives MedMira's strategic initiatives forward. Mr. Kuypers will assist with the transfer of the company's financial leadership and day-to-day functions to Mr. Meile and his team during a defined transition period.

Mr. Meile has served as a member of MedMira's board of directors since 2010, was previously a member of its audit committee and, most recently, led the company's business development activities as senior director, international markets. Effectively immediately, Mr. Meile will step down from the board to move into his new role as chief financial officer.

"On behalf of the board and the management team, I would like to thank Mr. Kuypers for his contributions to MedMira and the support provided to the company during this transition period. Mr. Kuypers has helped MedMira move to an enhanced financial foundation, upon which our future success will be built," said Hermes Chan, chief executive officer of MedMira.

Prior to joining MedMira, Mr. Meile worked with a number of financial institutions in Switzerland, England and Hong Kong. Mr. Meile holds a BSc from Royal Holloway University of London, and has studied business management, strategic planning, investment and accounting at a business school in Zurich. Previously, Mr. Meile worked in the medical device industry in Africa, Asia Pacific and Europe. Mr. Meile will combine his financial expertise with his broad range of international business knowledge to build financial and corporate strategies supporting MedMira's continuing growth and increasing shareholder value.

Mr. Meile's appointment as MedMira's chief financial officer is subject to final approval of the TSX Venture Exchange.

We seek Safe Harbor.